menu search

Bioxytran Announces Broad Spectrum Antiviral Activity Highlighted in ProLectin-M

Bioxytran Announces Broad Spectrum Antiviral Activity Highlighted in ProLectin-M
BOSTON, MASSACHUSETTS, Sept. 14, 2023 (GLOBE NEWSWIRE) — BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral drugs to treat COVID-19 and other viral diseases, announced that its preprint article titled “Evaluation of Complex Carbohydrates Showing Broad-Spectrum Antiviral Activity Against SARS-CoV-2, Influenzas-a (H1N1), and Human Respiratory Syncytial Virus (hRSV) Strain A2 in […] The post Bioxytran Announces Broad Spectrum Antiviral Activity Highlight... Read More
Posted: Sep 14 2023, 13:41
Author Name: forextv
Views: 092042

Search within

Pages Search Results: